Print ISSN:-2395-1354
Online ISSN:-2395-1362
CODEN : IJOSHC
Original Article
Author Details :
Volume : 7, Issue : 1, Year : 2021
Article Page : 57-61
https://doi.org/10.18231/j.ijos.2021.009
Abstract
Background: Periarthritis shoulder is the most common cause of shoulder pain and stiffness encountered in day to day practice. Though the condition is self-limiting it may not be practical to wait for spontaneous resolution as it is associated with significant morbidity hampering routine activities. The various treatment options available include simple physiotherapy, intra articular injections, manipulation under general anaesthesia and surgical intervention. This study was undertaken to compare the efficacy and safety of two intraarticular injections that is triamcinolone acetonide and platelet rich plasma (PRP).
Materials and Methods: Patients with periarthritis shoulder were randomly allocated into two groups. Group A receiving intraarticular triamcinolone acetonide injection and Group B receiving intra articular platelet rich plasma. Patients were followed up every four weeks for 24 weeks. And outcome was assessed using SPADI score before treatment and at every visit. Results were assessed using Epi Data version 2.2.2.186.
Results: PRP treatment resulted in statistically significant improvement over triamcinolone acetate therapy in both SPADI and VAS scale.
Conclusion: Intraarticular PRP is more effective and safe in treatment of periarthritis shoulder.
Keywords: Periarthritis shoulder, Triamcinolone acetonide, Platelet rich plasma.
How to cite : Vinod Kumar A C, Poovaiah, Ravish V N, Randomized controlled trial of functional outcome of periarthritis of shoulder (Adhesive Capsulitis) in a group of 60 patients using intraarticular triamcinolone vs. intraarticular platelet rich plasma. Indian J Orthop Surg 2021;7(1):57-61
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.